Browse studies
Find your next paid study
50 recruiting studies matching your filters
Phase 1
An Open-Label, Dose Escalation, Phase I/II Clinical Trial of ET140203 T Cells in Pediatric Subjects With Relapsed/Refractory Hepatoblastoma (HB), Hepatocellular Neoplasm-Not Otherwise Specified (HCN-NOS), or Hepatocellular Carcinoma (HCC)
Open-label, dose escalation, multi-center, Phase I/II clinical trial to assess the safety/tolerability and determine the recommended Phase II Dose (RP2D) of ET…
HepatoblastomaHepatocellular Carcinoma (HCC)Liver Neoplasms+3 more
Estimated
~$10 – $8,750
Eureka Therapeutics Inc.NCT04634357
Phase 2
Repurposing Riluzole for Augmenting Brain-Derived Neuropathic Factor (BDNF) Levels and Cognitive Function in Patients Experiencing Cancer-Related Cognitive Impairment: An Interventional Pilot Clinical Trial
This is a phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining the impact of riluzole therapy on circulating brain derived…
Breast CancerSarcomaGastric Cancer+7 more
Estimated
~$10 – $6,250
University of California, IrvineNCT06580002